A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Clinical trial NCT04044950 · WITHDRAWN
Trial details
- NCT number
- NCT04044950
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2020-09-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.